You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PROPAFENONE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Propafenone Hydrochloride, and what generic alternatives are available?

Propafenone Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Mylan, Rising, Sinotherapeutics Inc, Strides Pharma, Twi Pharms, Upsher Smith Labs, Watson Labs Inc, Zydus Lifesciences, Ani Pharms, Aurobindo Pharma, Nesher Pharms, Sun Pharm Industries, and Watson Labs. and is included in sixteen NDAs.

The generic ingredient in PROPAFENONE HYDROCHLORIDE is propafenone hydrochloride. There are eleven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Propafenone Hydrochloride

A generic version of PROPAFENONE HYDROCHLORIDE was approved as propafenone hydrochloride by WATSON LABS on October 24th, 2000.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PROPAFENONE HYDROCHLORIDE?
  • What are the global sales for PROPAFENONE HYDROCHLORIDE?
  • What is Average Wholesale Price for PROPAFENONE HYDROCHLORIDE?
Summary for PROPAFENONE HYDROCHLORIDE
US Patents:0
Applicants:15
NDAs:16
Finished Product Suppliers / Packagers: 19
Raw Ingredient (Bulk) Api Vendors: 105
Clinical Trials: 28
Patent Applications: 1,032
What excipients (inactive ingredients) are in PROPAFENONE HYDROCHLORIDE?PROPAFENONE HYDROCHLORIDE excipients list
DailyMed Link:PROPAFENONE HYDROCHLORIDE at DailyMed
Drug patent expirations by year for PROPAFENONE HYDROCHLORIDE
Recent Clinical Trials for PROPAFENONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
RenJi HospitalPhase 4
Rambam Health Care CampusEarly Phase 1
Rabin Medical CenterEarly Phase 1

See all PROPAFENONE HYDROCHLORIDE clinical trials

Pharmacology for PROPAFENONE HYDROCHLORIDE
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for PROPAFENONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PROPAFENONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for PROPAFENONE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
RYTHMOL SR Extended-release Capsules propafenone hydrochloride 325 mg 021416 1 2006-11-07
RYTHMOL SR Extended-release Capsules propafenone hydrochloride 225 mg and 425 mg 021416 1 2006-10-11

US Patents and Regulatory Information for PROPAFENONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075938-002 Oct 17, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-002 Apr 23, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 075998-003 Nov 29, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 214184-001 Apr 21, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms PROPAFENONE HYDROCHLORIDE propafenone hydrochloride TABLET;ORAL 076550-003 Apr 23, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 214184-002 Apr 21, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd PROPAFENONE HYDROCHLORIDE propafenone hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 213096-001 Feb 21, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.